https://www.expertsinpharma.pl/numer-52018/medimmune-astrazeneca-uzyskuje-zgode-ke-nawprowadzenie-do-obrotu-leku-imfinzi-we-wskazaniu-miejscowo-zaawansowanego-niedrobnokomorkowego-raka-pluca,p69055557
MedImmune AstraZeneca uzyskuje zgodę KE na wprowadzenie do obrotu leku Imfinzi we wskazaniu...
AstraZeneca oraz jej globalne ramię prowadzące prace badawcze i rozwojowe w obszarze leków biologicznych MedImmune, poinformowały, że Komisja Europejska wydała...
medimmuneastrazenecawprowadzenielekuimfinzi
https://www.selectleaders.com/employer/profile/7913/medimmune/
Learn About MedImmune - NY | SelectLeaders
Dive into the profile of MedImmune. Discover their business, values and career opportunities in real estate.
learnmedimmune
https://biohealthinnovation.org/medimmune-inks-6-5-million-r-d-partnership-with-johns-hopkins-baltimore-business-journal/
MedImmune inks $6.5 million R&D partnership with Johns Hopkins - Baltimore Business Journal -...
May 22, 2025 - MedImmune announced on Wednesday a $6.5 million research partnership with Johns Hopkins University, marking the second academic collaboration inked by the...
baltimore business journaljohns hopkinsmedimmuneinksmillion
https://www.astrazeneca.se/media/pressmeddelanden/svenska_pressmeddelanden/2015/medimmune-and-immunocore-announce-16042015.html
Medimmune and Immunocore announce new collaboration to conduct immuno-oncology combination trials...
medimmuneimmunocoreannouncenewcollaboration
https://salesandmarketingnetwork.com/news_release_bs.html?pipe=0000ac177000191&ID=2015948&key=Sun+Pharmaceutical+Industries
News for Medical Sales Reps: MedImmune Announces District Court's Rejection of Sun Pharmaceutical's...
sales repsdistrict courtsun pharmaceuticalnewsmedical